Cargando…

Amphiphilic Anionic Oligomer-Stabilized Calcium Phosphate Nanoparticles with Prospects in siRNA Delivery via Convection-Enhanced Delivery

Convection-enhanced delivery (CED) has been introduced as a concept in cancer treatment to generate high local concentrations of anticancer therapeutics and overcome the limited diffusional distribution, e.g., in the brain. RNA interference provides interesting therapeutic options to fight cancer ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitrach, Franziska, Schmid, Maximilian, Toussaint, Magali, Dukic-Stefanovic, Sladjana, Deuther-Conrad, Winnie, Franke, Heike, Ewe, Alexander, Aigner, Achim, Wölk, Christian, Brust, Peter, Hacker, Michael C., Schulz-Siegmund, Michaela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877163/
https://www.ncbi.nlm.nih.gov/pubmed/35214058
http://dx.doi.org/10.3390/pharmaceutics14020326
_version_ 1784658346003922944
author Mitrach, Franziska
Schmid, Maximilian
Toussaint, Magali
Dukic-Stefanovic, Sladjana
Deuther-Conrad, Winnie
Franke, Heike
Ewe, Alexander
Aigner, Achim
Wölk, Christian
Brust, Peter
Hacker, Michael C.
Schulz-Siegmund, Michaela
author_facet Mitrach, Franziska
Schmid, Maximilian
Toussaint, Magali
Dukic-Stefanovic, Sladjana
Deuther-Conrad, Winnie
Franke, Heike
Ewe, Alexander
Aigner, Achim
Wölk, Christian
Brust, Peter
Hacker, Michael C.
Schulz-Siegmund, Michaela
author_sort Mitrach, Franziska
collection PubMed
description Convection-enhanced delivery (CED) has been introduced as a concept in cancer treatment to generate high local concentrations of anticancer therapeutics and overcome the limited diffusional distribution, e.g., in the brain. RNA interference provides interesting therapeutic options to fight cancer cells but requires nanoparticulate (NP) carriers with a size below 100 nm as well as a low zeta potential for CED application. In this study, we investigated calcium phosphate NPs (CaP-NPs) as siRNA carriers for CED application. Since CaP-NPs tend to aggregate, we introduced a new terpolymer (o14PEGMA(1:1:2.5) NH(3)) for stabilization of CaP-NPs intended for delivery of siRNA to brain cancer cells. This small terpolymer provides PEG chains for steric stabilization, and a fat alcohol to improve interfacial activity, as well as maleic anhydrides that allow for both labeling and high affinity to Ca(II) in the hydrolyzed state. In a systematic approach, we varied the Ca/P ratio as well as the terpolymer concentration and successfully stabilized NPs with the desired properties. Labeling of the terpolymer with the fluorescent dye Cy5 revealed the terpolymer’s high affinity to CaP. Importantly, we also determined a high efficiency of siRNA binding to the NPs that caused very effective survivin siRNA silencing in F98 rat brain cancer cells. Cytotoxicity investigations with a standard cell line resulted in minor and transient effects; no adverse effects were observed in organotypic brain slice cultures. However, more specific cytotoxicity investigations are required. This study provides a systematic and mechanistic analysis characterizing the effects of the first oligomer of a new class of stabilizers for siRNA-loaded CaP-NPs.
format Online
Article
Text
id pubmed-8877163
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88771632022-02-26 Amphiphilic Anionic Oligomer-Stabilized Calcium Phosphate Nanoparticles with Prospects in siRNA Delivery via Convection-Enhanced Delivery Mitrach, Franziska Schmid, Maximilian Toussaint, Magali Dukic-Stefanovic, Sladjana Deuther-Conrad, Winnie Franke, Heike Ewe, Alexander Aigner, Achim Wölk, Christian Brust, Peter Hacker, Michael C. Schulz-Siegmund, Michaela Pharmaceutics Article Convection-enhanced delivery (CED) has been introduced as a concept in cancer treatment to generate high local concentrations of anticancer therapeutics and overcome the limited diffusional distribution, e.g., in the brain. RNA interference provides interesting therapeutic options to fight cancer cells but requires nanoparticulate (NP) carriers with a size below 100 nm as well as a low zeta potential for CED application. In this study, we investigated calcium phosphate NPs (CaP-NPs) as siRNA carriers for CED application. Since CaP-NPs tend to aggregate, we introduced a new terpolymer (o14PEGMA(1:1:2.5) NH(3)) for stabilization of CaP-NPs intended for delivery of siRNA to brain cancer cells. This small terpolymer provides PEG chains for steric stabilization, and a fat alcohol to improve interfacial activity, as well as maleic anhydrides that allow for both labeling and high affinity to Ca(II) in the hydrolyzed state. In a systematic approach, we varied the Ca/P ratio as well as the terpolymer concentration and successfully stabilized NPs with the desired properties. Labeling of the terpolymer with the fluorescent dye Cy5 revealed the terpolymer’s high affinity to CaP. Importantly, we also determined a high efficiency of siRNA binding to the NPs that caused very effective survivin siRNA silencing in F98 rat brain cancer cells. Cytotoxicity investigations with a standard cell line resulted in minor and transient effects; no adverse effects were observed in organotypic brain slice cultures. However, more specific cytotoxicity investigations are required. This study provides a systematic and mechanistic analysis characterizing the effects of the first oligomer of a new class of stabilizers for siRNA-loaded CaP-NPs. MDPI 2022-01-29 /pmc/articles/PMC8877163/ /pubmed/35214058 http://dx.doi.org/10.3390/pharmaceutics14020326 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mitrach, Franziska
Schmid, Maximilian
Toussaint, Magali
Dukic-Stefanovic, Sladjana
Deuther-Conrad, Winnie
Franke, Heike
Ewe, Alexander
Aigner, Achim
Wölk, Christian
Brust, Peter
Hacker, Michael C.
Schulz-Siegmund, Michaela
Amphiphilic Anionic Oligomer-Stabilized Calcium Phosphate Nanoparticles with Prospects in siRNA Delivery via Convection-Enhanced Delivery
title Amphiphilic Anionic Oligomer-Stabilized Calcium Phosphate Nanoparticles with Prospects in siRNA Delivery via Convection-Enhanced Delivery
title_full Amphiphilic Anionic Oligomer-Stabilized Calcium Phosphate Nanoparticles with Prospects in siRNA Delivery via Convection-Enhanced Delivery
title_fullStr Amphiphilic Anionic Oligomer-Stabilized Calcium Phosphate Nanoparticles with Prospects in siRNA Delivery via Convection-Enhanced Delivery
title_full_unstemmed Amphiphilic Anionic Oligomer-Stabilized Calcium Phosphate Nanoparticles with Prospects in siRNA Delivery via Convection-Enhanced Delivery
title_short Amphiphilic Anionic Oligomer-Stabilized Calcium Phosphate Nanoparticles with Prospects in siRNA Delivery via Convection-Enhanced Delivery
title_sort amphiphilic anionic oligomer-stabilized calcium phosphate nanoparticles with prospects in sirna delivery via convection-enhanced delivery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877163/
https://www.ncbi.nlm.nih.gov/pubmed/35214058
http://dx.doi.org/10.3390/pharmaceutics14020326
work_keys_str_mv AT mitrachfranziska amphiphilicanionicoligomerstabilizedcalciumphosphatenanoparticleswithprospectsinsirnadeliveryviaconvectionenhanceddelivery
AT schmidmaximilian amphiphilicanionicoligomerstabilizedcalciumphosphatenanoparticleswithprospectsinsirnadeliveryviaconvectionenhanceddelivery
AT toussaintmagali amphiphilicanionicoligomerstabilizedcalciumphosphatenanoparticleswithprospectsinsirnadeliveryviaconvectionenhanceddelivery
AT dukicstefanovicsladjana amphiphilicanionicoligomerstabilizedcalciumphosphatenanoparticleswithprospectsinsirnadeliveryviaconvectionenhanceddelivery
AT deutherconradwinnie amphiphilicanionicoligomerstabilizedcalciumphosphatenanoparticleswithprospectsinsirnadeliveryviaconvectionenhanceddelivery
AT frankeheike amphiphilicanionicoligomerstabilizedcalciumphosphatenanoparticleswithprospectsinsirnadeliveryviaconvectionenhanceddelivery
AT ewealexander amphiphilicanionicoligomerstabilizedcalciumphosphatenanoparticleswithprospectsinsirnadeliveryviaconvectionenhanceddelivery
AT aignerachim amphiphilicanionicoligomerstabilizedcalciumphosphatenanoparticleswithprospectsinsirnadeliveryviaconvectionenhanceddelivery
AT wolkchristian amphiphilicanionicoligomerstabilizedcalciumphosphatenanoparticleswithprospectsinsirnadeliveryviaconvectionenhanceddelivery
AT brustpeter amphiphilicanionicoligomerstabilizedcalciumphosphatenanoparticleswithprospectsinsirnadeliveryviaconvectionenhanceddelivery
AT hackermichaelc amphiphilicanionicoligomerstabilizedcalciumphosphatenanoparticleswithprospectsinsirnadeliveryviaconvectionenhanceddelivery
AT schulzsiegmundmichaela amphiphilicanionicoligomerstabilizedcalciumphosphatenanoparticleswithprospectsinsirnadeliveryviaconvectionenhanceddelivery